Definitive Contract 75F40124C00068

The U.S. Food and Drug Administration (FDA) awarded an 8(a) sole source contract to Aneon Brillient, LLC, a minority-owned small disadvantaged business, for CDER science database administration support. The $485,507.74 labor-hour contract has an ultimate completion date of August 13, 2029. Aneon Brillient, LLC specializes in providing professional services to federal agencies, particularly the FDA, in areas such as medical product development, drug evaluation, and policy support. This award is...

This is a definitive contract awarded by the U.S. Food and Drug Administration (FDA) to Aneon Brillient, LLC, a Small Business Administration (SBA) certified 8(a) joint venture, for $326,304.48. The contract provides shipping, receiving, printing support, and administrative support services for the FDA's Office of Regulatory Affairs Office of Training, Education, and Development (OTED). The contract is set aside for 8(a) small businesses and has a performance period ending on September 29, 2026....

This is a direct 8(a) sole source award of a 12-month base and 9-month option, labor hour type contract to Aneon Brillient, LLC for the U.S. Food and Drug Administration's (FDA) Center for Drug Evaluation and Research (CDER) to provide professional services. The contract has a ceiling value of $4,277,014.63 and an ultimate completion date of May 31, 2026. Aneon Brillient is a minority-owned, small disadvantaged business certified as an SBA 8(a) joint venture. The company has a history of...

This is a $144,964.92 sole source 8(a) contract awarded by the Food and Drug Administration (FDA) to Aneon Brillient, LLC, a minority-owned small disadvantaged business. The contract is for additive manufacturing of medical products core facility support, on a labor-hour basis. Aneon Brillient is an SBA-certified 8(a) joint venture that specializes in providing professional services to the FDA, including across the Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation...

This award represents a 1-year, $190,357.34 time and materials contract for information technology professional services awarded by the U.S. Food and Drug Administration's (FDA) Center for Drug Evaluation and Research (CDER) to Aneon Brillient, LLC, an SBA-certified 8(a) joint venture. The contract supports the Office of Pharmaceutical Quality within CDER. As an 8(a) sole source award, this contract leverages the SBA's business development program to provide specialized IT services to the FDA....

The U.S. Food and Drug Administration (FDA) awarded a 4-year, labor-hour type contract worth $2,133,514.80 to Aneon Brillient, LLC, a Small Disadvantaged Business and 8(a) Joint Venture. The contract is for medical and scientific writing and editing services to support the FDA's Center for Drug Evaluation and Research (CDER). This award was a direct 8(a) sole source contract and did not have a set-aside designation. Aneon Brillient has a history of providing professional services to the FDA,...

This is a $642,543.27 definitive contract awarded by the Food and Drug Administration (FDA) to Aneon Brillient, LLC, an 8(a) certified small disadvantaged business, to provide transcription services to support the Center for Drug Evaluation and Research (CDER) advisory committee meetings. The contract has a completion date of February 27, 2026 and is a sole source award under the 8(a) program. Aneon Brillient specializes in providing professional services to the FDA, including medical and...

This is a direct 8(a) award of a 12-month, labor-hour type contract to Aneon Brillient, LLC for the U.S. Food and Drug Administration's (FDA) Center for Drug Evaluation and Research (CDER) to provide professional services support. The contract has a ceiling value of $3,266,346.36 and does not utilize a set-aside. Aneon Brillient is a minority-owned, small disadvantaged business registered as an 8(a) joint venture that specializes in providing a range of professional services to the FDA,...

This is a firm fixed price purchase order contract awarded by the Food and Drug Administration (FDA) to Aneon Brillient, LLC, a minority-owned, small disadvantaged business certified as an SBA 8(a) joint venture. The contract, valued at $192,142.38, is for a Quality Assurance Specialist III to support the FDA's Center for Drug Evaluation and Research (CDER) and Office of Pharmaceutical Quality (OPQ). The contract has an ultimate completion date of August 29, 2025. Aneon Brillient specializes...

This is a federal contract award from the Department of Health and Human Services (HHS) Food and Drug Administration (FDA) to Brillient Corporation, a Minority Owned, Subcontinent Asian American-Owned business, for professional services related to the FDA's Oncology Center for Excellence (OCE). The contract is a Blanket Purchase Agreement (BPA) call under the General Services Administration (GSA) Professional Services Schedule (PSS), with a potential value of $255,095.76 and a completion date of...